China Plasma Protein Market: Trends and Opportunities (2015-2019)

China Plasma Protein Market: Trends and Opportunities (2015-2019)

Scope of the Report

The report titled “China Plasma Protein Market: Trends and Opportunities (2015-2019)” analyzes the potential opportunities, challenges, demand drivers and significant trends representing the Plasma Protein market in China. The report elucidates facts on theChina Plasma Proteins Market as supplemented by the latest available statistics. The report gives valuable insight into technology used in China Plasma Proteins market, its demand and supply. It also profiles and analyzes the leading five companies operating in this industry with latest data and a brief overview of their business and finance structure along with a brief discussion of their future business strategies. In the report, we also try to study the growth pattern in the production and revenue earned by the China Plasma Protein companies and the latest trends concerning China Plasma Proteins. Most importantly, we have analyzed the current market size and project future market size of the overall China Plasma Protein market for the years to come.

Products Covered

Company Coverage

China Biologic Product
Hualan Biological Engineering
Beijing Tiantan
Shanghai RAAS Blood Products
CSL Ltd.

Executive Summary

Plasma proteins, also termed as Serum Proteins or Blood Proteins, are proteins present in blood plasma. They serve different functions, including transport of lipids, hormones, vitamins and minerals in the circulatory system and the regulation of acellular activity and functioning of the immune system. Other blood proteins act as enzymes, complement components, protease inhibitors or kinin precursors.

The Chinese plasma protein market is heavily regulated and the market is characterized by supply shortages that provide lucrative opportunities to the leading companies operating in the sector. The main driving force of Plasma Proteins market in China is high demand of albumin in China, rapidly growing IVIG market, and rising expenditure on China healthcare sector.

Although, China Plasma Protein market is growing, there are some challenges that need to be addressed. These challenges include less expansion of Plasma Protein market, strict regulations such as ban on import of IVIG and FactorVIII and changes in China’s political and economic stability. Despite challenges like stringent regulations, ensuring adequate supply of human plasma and high cost of treatment in China Blood Plasma Proteins market, the Chinese IVIG market is all set to witness high growth in the coming years as a result of multiple factors such as growing ageing population, increasing number of patients with bleeding disorder and rising healthcare expenditure.

1. Executive Summary
2. Introduction to Plasma Protein Industry
Table1: Composition of Blood Cells
Table 2: Composition of Blood Plasma
Table 3: Composition of Blood Plasma Proteins
2.1. History of Plasma Proteins Fractionation
2.2. Types of Plasma Proteins
2.2.1 Albumin
2.2.2 Intravenous Immunoglobulin (IGIV)
2.2.3 Factor VIII
2.2.4 A1PI
2.3. Clinical uses of Plasma Protein Products
2.4. Concept of Plasma Economics
2.5. Detailed Description of Plasma Collection Method
2.5.1 Plasma Collection
Table A: Recovered Plasma versus Source Plasma
2.5.2 Plasma Extraction
Table 4: Flow-Chart of Plasma Extraction
2.5.3 Plasma Fractionation Yield
Table B: Output per Litre of Plasma
2.5.4 Plasma Usage
2.5.5 Steps to Assure Safe Plasma from Healthy Donors
Table 5: Steps to Assure Safe Plasma Collection from Healthy Donors
3. Global Blood Plasma Market: Size and Growth (2010-2019)
Table 6: Global Blood Plasma Market-(US$ Billion)-2010-2014
Table 7: Global Blood Plasma Market Forecast-(US$ Billion)-2015-2019
4. China Plasma Protein Market: An Analysis
Table 8: China Plasma Proteins Market-(US$ Billion)-2010-2014
Table 9: Chinese Plasma Proteins Market Forecast-(US$ Billion)-2015-2019
4.1 Chinese Plasma Protein Market Segmentation
4.1.1 Chinese Albumin Market: Actual and Forecast
Table 10: China Albumin Market-(US$ Billion)-2010-2014
Table 11: China Albumin Market Forecast-(US$ Billion)-2015-2019
4.1.2 Domestic Supply of Albumin in China: Actual & Forecast
Table 12: Domestic Supply of Albumin in China-(Tonnes)-2010-2013
Table 13: China Albumin Market Domestic Supply-(Tonnes)-2014-2019
4.1.3 Import of Albumin in China: Actual & Forecast
Table 14: China Albumin Market Import Supply-(Tonne) 2010-2013
Table 15: China Albumin Market Import Supply-(Tonnes)-2014-2019
4.2 Chinese IVIG Market: Actual & Forecast
Table 16: Chinese IVIG Market-(US$ Million)-2010-2014
Table 17: Chinese IVIG Market Forecast-(US$ Million)-2015-2019
4.3 Chinese Factor VIII Market: Actual & Forecast
Table 18: China FactorVIII Market- (US$ Million) -2010-2014
Table 19: China FactorVIII Market Forecast-(US$ Million)-2015-2019
5. China Plasma Proteins Market Share: An Analysis
5.1 China Blood Plasma Market Share: By Revenue
Table 20: Blood Plasma Proteins Market Share-(Percentage)-2014
5.2 China Plasma Proteins Market Share: Segments
Table 21: China Plasma Proteins Market Share-(Percentage)-2014
5.3 China Albumin Market Share: By Consumption
Table 22: China Albumin Consumption Market Share-(Percentage)-2013
5.4 China Plasma Proteins Market Share: By Pharmaceutical Sales
Table 23: China Plasma Protein Market Share in China Pharmaceutical Market-(Percentage)-2013
Table 24: China Plasma Protein Market Share in China Pharmaceutical Market (Percentage)-2014
6. China Plasma Protein Market: Facts and Statistical Analysis
6.1 China Plasma Protein Market Statistics Snapshot
Table C: China Plasma Protein Market Statistics Snapshot
6.2 China per Capita Expenditure on Medical Treatment
Table 25: China per Capita Expenditure on Medical Treatment- (USD)-2010-2014
6.3 China Plasma Market Regulations
Table D: China Plasma Regulations
7. China Plasma Protein Market Dynamics
7.1 Growth Drivers
7.1.1 High Demand of Albumin
7.1.2 Rapidly Growing SCIG/IVIG Market
7.1.3 Rising China Healthcare Expenditure
Table 26: China Healthcare Expenditure-2009-2013
7.1.4 GDP Growth in China
Table 27: GDP Growth Trend-(US$ Trillion)-2010-2014E
7.2 Market Trends
7.2.1 China Still at the Fast Growing Stage
7.2.2 Albumin Still Offers Opportunities for Exporters
7.2.3 High Entry Barriers for New Entrants Keep Supply Tight
7.3 Challenges
7.3.1 Less Expansion of Plasma Protein Market
7.3.2 Strict Regulations on China Plasma Proteins Market
7.3.3 Change in China’s Political or Economic Stability
8. Competitive Landscape:China Plasma Protein Market
China’s leading companies and their comparative analysis
Table 28: Comparative Analysis of China’s Leading Plasma Protein Companies – (US$ Million)-2014
Table 29: Comparative Analysis of China’s Leading Plasma Protein Companies – (US$ Million)-2015E
Table 30: Albumin Competitive Landscape in China-(Percentage)-2013
9. Company Profiles:China Plasma Protein Market
9.1 China Biologic Product Inc.
9.1.1 Business Overview
9.1.2 Financial Overview
Table 31: China Biologic Product Total Sales-(US$ Million)-2011-2014
Table 32: Revenue Break-Up of China Biologic Product by Sales-(Percentage)-2014
Table 33: Net Income of China Biologic Products-(US$ Million)-2011-2014
9.1.3 Business Strategies
Table 34: Expenditure in Research and Development-(US$ Million)-2011-2014
9.2 Hualan Biological Engineering Inc.
9.2.1 Business Overview
9.2.2 Financial Overview
Table 35: Hualan Biological Engineering Inc. Revenue-(US$ Million)-2010-2014
Table 36: Hualan Biological Engineering Inc. Net income - (US$ Million)-2010-2014
9.2.3 Business Strategies
9.3 Beijing Tiantan Biological Products Co. Ltd
9.3.1 Business Overview
9.3.2 Financial Overview
Table 37: Beijing Tiantan Biologic Products Co. Ltd. Revenue-(US$ Million)-2010-2014
Table 38: Net Income of Beijing Tiantan Biological Products-(US$ Million)-2010-2014
9.3.3 Business Strategies
9.4 Shanghai RAAS Blood Products Co. Ltd
9.4.1 Business Overview
9.4.2 Financial Overview
Table 39: Shanghai RAAS Blood Products Co. Ltd Revenue-(US$ Million)-2010-2014
Table 40: Shanghai RAAS Blood Products Co. Ltd Net Income-(US$ Million)-2010-2014
9.4.3 Business Strategy
9.5 CSL Ltd.
9.5.1 Business Overview
9.5.2. Financial Overview
Table 41: Total Revenue of CSL Group- (US$ Billion)-2009-2013
Table 42: Revenue Break-Up of CSL Group- (Geography)-2013
Table 43: Net profit of CSL Ltd. - (US$ Million)-2009-2013
9.5.3 Business Strategies
Table 44: Expenditure in Research and Development – (US$ Million)-2009-2010

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook